Companies: 10,795·Total market cap: $144.5T
Bausch + Lomb Corporation

Bausch + Lomb Corporation

BLCONYSEHealthcare● Active
$15.39
$-0.07(-0.45%)
Market Cap$5.5B
P/E Ratio
52W High$18.915
52W Low$11.44

Bausch + Lomb Corporation (BLCO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BLCO · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$383.0M +25.6% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$383.0M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+25.6%
vs prior fiscal year
Latest Quarter
$268.0M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$383.0MCash on Hand
Total Debt$5.37BTotal Debt
Net Cash / Net Debt−$4.99BNet Debt Position
Cash vs Debt Ratio
Cash 7%Debt 93%

Bausch + Lomb Corporation carries a net debt position of $4.99B. Total debt ($5.37B) exceeds cash on hand ($383.0M). Bausch + Lomb Corporation cash vs debt ratio: 7% cash / 93% debt.

Net Cash = Cash & ST Investments − Total Debt$383.0M$5.37B = −$4.99B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
BLCO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$383.0M+25.6%
Dec 31, 2024$305.0M-8.7%
Dec 31, 2023$334.0M-12.1%
Dec 31, 2022$380.0M+118.4%
Dec 31, 2021$174.0M-26.9%
BLCO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Bausch + Lomb Corporation
Bausch + Lomb CorporationYOU
BLCO
$383.0M7.0%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Bausch + Lomb Corporation (BLCO) cash on hand as of December 31, 2025 is $383.0M, comprising $383.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Bausch + Lomb Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Bausch + Lomb Corporation cash reserves or cash position.

Bausch + Lomb Corporation annual cash on hand history shows increased +25.6% in 2025: increased +25.6% in 2025. Bausch + Lomb Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Bausch + Lomb Corporation carries total debt of $5.37B against cash of $383.0M, resulting in a net debt position of -$4.99B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

BLCO cash on hand · 5 questions

As of December 31, 2025, Bausch + Lomb Corporation (BLCO) has $383,000,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $383,000,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $268,000,000. Data sourced from the annual 10-K filing via FMP.

BLCO cash on handBLCO cash reservesBLCO cash 2025how much cash does BLCO have

Source: FMP /balance-sheet-statement · US GAAP · Bausch + Lomb Corporation · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025